Novel oxindole derivatives prevent oxidative stress-induced cell death in mouse hippocampal HT22 cells. (June 2018)
- Record Type:
- Journal Article
- Title:
- Novel oxindole derivatives prevent oxidative stress-induced cell death in mouse hippocampal HT22 cells. (June 2018)
- Main Title:
- Novel oxindole derivatives prevent oxidative stress-induced cell death in mouse hippocampal HT22 cells
- Authors:
- Hirata, Yoko
Yamada, Chika
Ito, Yuki
Yamamoto, Shotaro
Nagase, Haruna
Oh-hashi, Kentaro
Kiuchi, Kazutoshi
Suzuki, Hiromi
Sawada, Makoto
Furuta, Kyoji - Abstract:
- Abstract: The current medical and surgical therapies for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease offer symptomatic relief but do not provide a cure. Thus, small synthetic compounds that protect neuronal cells from degeneration are critically needed to prevent and treat these. Oxidative stress has been implicated in various pathophysiological conditions, including neurodegenerative diseases. In a search for neuroprotective agents against oxidative stress using the murine hippocampal HT22 cell line, we found a novel oxindole compound, GIF-0726-r, which prevented oxidative stress-induced cell death, including glutamate-induced oxytosis and erastin-induced ferroptosis. This compound also exerted a protective effect on tunicamycin-induced ER stress to a lesser extent but had no effect on campthothecin-, etoposide- or staurosporine-induced apoptosis. In addition, GIF-0726-r was also found to be effective after the occurrence of oxidative stress. GIF-0726-r was capable of inhibiting reactive oxygen species accumulation and Ca 2+ influx, a presumed executor in cell death, and was capable of activating the antioxidant response element, which is a cis -acting regulatory element in promoter regions of several genes encoding phase II detoxification enzymes and antioxidant proteins. These results suggest that GIF-0726-r is a low-molecular-weight compound that prevents neuronal cell death through attenuation of oxidative stress. Among the more thanAbstract: The current medical and surgical therapies for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease offer symptomatic relief but do not provide a cure. Thus, small synthetic compounds that protect neuronal cells from degeneration are critically needed to prevent and treat these. Oxidative stress has been implicated in various pathophysiological conditions, including neurodegenerative diseases. In a search for neuroprotective agents against oxidative stress using the murine hippocampal HT22 cell line, we found a novel oxindole compound, GIF-0726-r, which prevented oxidative stress-induced cell death, including glutamate-induced oxytosis and erastin-induced ferroptosis. This compound also exerted a protective effect on tunicamycin-induced ER stress to a lesser extent but had no effect on campthothecin-, etoposide- or staurosporine-induced apoptosis. In addition, GIF-0726-r was also found to be effective after the occurrence of oxidative stress. GIF-0726-r was capable of inhibiting reactive oxygen species accumulation and Ca 2+ influx, a presumed executor in cell death, and was capable of activating the antioxidant response element, which is a cis -acting regulatory element in promoter regions of several genes encoding phase II detoxification enzymes and antioxidant proteins. These results suggest that GIF-0726-r is a low-molecular-weight compound that prevents neuronal cell death through attenuation of oxidative stress. Among the more than 200 derivatives of the GIF-0726-r synthesized, we identified the 11 most potent activators of the antioxidant response element and characterized their neuroprotective activity in HT22 cells. Graphical abstract: Highlights: Novel oxindole compounds prevent oxidative stress-induced cell death. The lead compound GIF-0726-r inhibits ROS accumulation and Ca 2+ influx. GIF-2165X-G1, obtained by chemical modification of GIF-0726-r, is a potent ARE inducer. … (more)
- Is Part Of:
- Neuropharmacology. Volume 135(2018)
- Journal:
- Neuropharmacology
- Issue:
- Volume 135(2018)
- Issue Display:
- Volume 135, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 135
- Issue:
- 2018
- Issue Sort Value:
- 2018-0135-2018-0000
- Page Start:
- 242
- Page End:
- 252
- Publication Date:
- 2018-06
- Subjects:
- ER stress -- Ferroptosis -- Oxidative stress -- Oxindole -- Oxytosis -- Rasagiline
ATF6 activated transcription factor 6 -- ARE antioxidant response element -- DMEM Dulbecco's modified Eagle's medium -- ER endoplasmic reticulum -- Grp78 78-kDa glucose-regulated protein -- GSH glutathione -- GAPDH glyceraldehyde 3 phosphate dehydrogenase -- GADD153 growth arrest- and DNA damage-inducible gene 153 -- HO-1 hemoxygenase-1 -- 6-OHDA 6-hydroxydopamine -- IRE1 inositol-requiring enzyme 1 -- LDH lactate dehydrogenase -- MAO-B monoamine oxidase-B -- NQO NAD(P)H:quinone reductase -- Nrf2 nuclear factor (erythroid-derived 2)-like 2 -- PAGE polyacrylamide gel electrophoresis -- PARP poly(ADP-ribose) polymerase -- PERK protein kinase RNA-like ER kinase -- ROS reactive oxygen species -- RT-PCR reverse transcription-polymerase chain reaction -- UPR unfolded protein response -- SIN-1 3-morpholinosydnonimine hydrochloride -- XBP1 X-box binding protein 1
Neuropsychopharmacology -- Periodicals
Autonomic Agents -- Periodicals
Neuropsychopharmacologie -- Périodiques
Neuropsychopharmacology
Periodicals
Electronic journals
615.78 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00283908 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.neuropharm.2018.03.015 ↗
- Languages:
- English
- ISSNs:
- 0028-3908
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.517500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 6621.xml